Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix injection technique and route comparison in prostate cancer
2015-000357-20Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Jul 2015; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2015-000357-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000357-20.